These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10334690)

  • 1. Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor.
    Daikeler T; Günaydin I; Einsele H; Kanz L; Kötter I
    Rheumatology (Oxford); 1999 Jan; 38(1):89-90. PubMed ID: 10334690
    [No Abstract]   [Full Text] [Related]  

  • 2. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
    Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
    Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia.
    Kraut L; Trebeljahr G; Thiele B; Fauser AA
    Bone Marrow Transplant; 2005 Oct; 36(8):737. PubMed ID: 16086042
    [No Abstract]   [Full Text] [Related]  

  • 4. [Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
    Liem GS; Cornelissen JJ; Oudshoorn M; Sintnicolaas K; Löwenberg B; Hagenbeek A
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1553-6. PubMed ID: 9543748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated optic neuritis after unrelated allogeneic bone marrow transplantation.
    Ooi J; Takahashi S; Tajika K; Tojo A; Tani K; Asano S
    Blood; 1998 Apr; 91(7):2619. PubMed ID: 9516165
    [No Abstract]   [Full Text] [Related]  

  • 6. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
    O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
    Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of four marrow transplant centers.
    Beatty PG; Ash R; Hows JM; McGlave PB
    Bone Marrow Transplant; 1989 May; 4(3):287-90. PubMed ID: 2659114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Hermans J; Labopin M; Apperley J; Gorin NC; Gratwohl A
    Leuk Lymphoma; 1996 Dec; 24(1-2):71-9. PubMed ID: 9049963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR; Ji SQ; Wang HX; Yan HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization.
    Lowsky R; Fyles G; Minden M; Lipton J; Meharchand J; Tejpar I; Zipursky A; Messner H
    Br J Haematol; 1996 Apr; 93(1):163-5. PubMed ID: 8611454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
    Szydlo R; Goldman JM; Klein JP; Gale RP; Ash RC; Bach FH; Bradley BA; Casper JT; Flomenberg N; Gajewski JL; Gluckman E; Henslee-Downey PJ; Hows JM; Jacobsen N; Kolb HJ; Lowenberg B; Masaoka T; Rowlings PA; Sondel PM; van Bekkum DW; van Rood JJ; Vowels MR; Zhang MJ; Horowitz MM
    J Clin Oncol; 1997 May; 15(5):1767-77. PubMed ID: 9164184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma.
    Au WY; Chan EC; Siu LL; Lau TC; Lie AK; Ma SK; Kwong YL
    Br J Haematol; 2002 Dec; 119(3):777-80. PubMed ID: 12437659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allografting for chronic myeloid leukaemia.
    Clift RA; Anasetti C
    Baillieres Clin Haematol; 1997 Jun; 10(2):319-36. PubMed ID: 9376667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow transplantation in chronic myeloid leukemia].
    Hansz J
    Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
    Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
    [No Abstract]   [Full Text] [Related]  

  • 17. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
    Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
    Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor.
    Fahy CM; Fortune A; Quinn F; McMenamin ME; Browne PV; Langabeer S; McCarron S; Hayden P; Marren P; Ni Chonghaile M; Irvine AD; Vandenberghe E; Barnes L
    Br J Dermatol; 2014 Feb; 170(2):462-7. PubMed ID: 24116988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.